The Micropore HORIZON™ series enables precise, reproducible particle and emulsion formation, helping users simplify scale-up and improve process reliability
Built on proven Advanced Crossflow (AXF) technology, the HORIZON™ platform addresses one of the industry’s most persistent challenges—quickly and easily translating formulations from R&D to full-scale production.
Enabling low-shear emulsification and precise, controlled particle formation, the system delivers highly reproducible and reliable results across a wide range of applications, including pharmaceuticals, CDMOs, and encapsulation processes.
The HORIZON™ range has been thoughtfully designed with scalability and efficiency in mind. From the compact HORIZON™ mini for development and pilot-scale work, to the industrial-scale HORIZON™ one, and the fully customisable HORIZON™ PRO, users can confidently scale processes without the need for extensive re-optimisation.
Continuous processing, low holdup volumes, and sanitary design further enhance productivity by reducing downtime and simplifying cleaning between batches.
The system has the ability to produce consistent, monodispersed particles across varying volumes and lipid nanoparticle (LNP) chemistries—highlighting its robustness and flexibility in demanding applications such as intracellular drug delivery.
HORIZON™ platform as a transformative solution for organisations seeking to accelerate development timelines while reducing scale-up risk and cost. By bridging the gap between laboratory innovation and commercial manufacturing, Micropore Technologies sets a new benchmark for particle engineering.